ProFibrix's Grant

ProFibrix raised a round of funding on January 22, 2010. Investors include SenterNovem.

ProFibrix leverages its expertise in fibrinogen technology to develop and market products for the hemostasis and regenerative medicine markets. Human fibrinogen plays a pivotal role in blood clotting …

Articles about ProFibrix's Grant: